
Sign up to save your podcasts
Or
In this week’s View, Dr. Eagle looks at Lp(a) levels and cardiovascular (CV) risk. He then discusses the potential value of high-sensitivity C-reactive protein (hsCRP) in identifying high-risk and more vulnerable plaque in patients after non-ST-segment elevation myocardial infarction (STEMI). Finally, Dr. Eagle explores pulsed field ablation versus cryoablation for paroxysmal atrial fibrillation (AFib).
Subscribe to Eagle’s Eye View
4.7
127127 ratings
In this week’s View, Dr. Eagle looks at Lp(a) levels and cardiovascular (CV) risk. He then discusses the potential value of high-sensitivity C-reactive protein (hsCRP) in identifying high-risk and more vulnerable plaque in patients after non-ST-segment elevation myocardial infarction (STEMI). Finally, Dr. Eagle explores pulsed field ablation versus cryoablation for paroxysmal atrial fibrillation (AFib).
Subscribe to Eagle’s Eye View
128 Listeners
318 Listeners
160 Listeners
860 Listeners
485 Listeners
32 Listeners
271 Listeners
83 Listeners
1,091 Listeners
53 Listeners
39 Listeners
184 Listeners
321 Listeners
409 Listeners
37 Listeners